Medtronic wins FDA’s breakthrough status for closed-loop insulin system

Medtronic (NYSE:MDT) said today that it won breakthrough status from the FDA for its investigational personalized closed-loop insulin pump system.

The company touted its technology as enabling automated insulin delivery in a real-time, adaptable and personalized fashion.

Get the full story at our sister site, Drug Delivery Business News.

The post Medtronic wins FDA’s breakthrough status for closed-loop insulin system appeared first on MassDevice.

from MassDevice http://bit.ly/2T6a6ms